RESUMO
Not all medical practices are equipped to provide diabetes self-management training. Physicians can incorporate a team approach in their practice by establishing collaborative relationships with recognized diabetes education programs. The ADA's education recognition program has identified diabetes education programs that meet the National Standards for Diabetes Self-Management Education Programs. This list is available on the ADA's web site at http://www.diabetes.org/recognition and is printed twice a year in Diabetes Forecast. The National Certification Board for Diabetes Educators (NDEA) can provide a list of CDEs in your area. The South Carolina Model Diabetes Patient Education Program of DSC and SCDCP/DHEC is an excellent critical step towards obtaining ADA recognition.
Assuntos
Diabetes Mellitus , Educação de Pacientes como Assunto , Diabetes Mellitus/prevenção & controle , Humanos , Reembolso de Seguro de Saúde , Modelos Educacionais , South CarolinaRESUMO
Transsphenoidal microdissection has been proposed as a preferred means of treating Cushing's disease. This procedure allows the surgeon to remove a pituitary microadenoma and at the same time to preserve normal tissue. Two cases described here were treated by this method. An interesting and important observation was that neither patient appeared to be cured for 2 to 6 weeks after surgery, as assessed by dexamethasone suppression. Later, normal suppressibility occurred and the course of each patient was compatible with cure. Patients treated by this method should not be automatically retreated because of adrenocorticotropic hormone (ACTH) non-suppressibility in the early postoperative period.
Assuntos
Adenoma Cromófobo/cirurgia , Síndrome de Cushing/cirurgia , Neoplasias Hipofisárias/cirurgia , Adenoma Cromófobo/complicações , Hormônio Adrenocorticotrópico/metabolismo , Adulto , Síndrome de Cushing/diagnóstico , Síndrome de Cushing/etiologia , Dexametasona , Feminino , Humanos , Hipofisectomia/métodos , Masculino , Neoplasias Hipofisárias/complicações , Fatores de TempoRESUMO
Patients treated with 10 mCi of I-131 for toxic diffuse goiter in the period January 1974--June 1976 were evaluated for development of hypothyroidism. Fifty percent were hypothyroid within 3 mo and 69% within 1 yr of treatment. Our data suggest that there is a higher incidence of hypothyroidism after standard doses of I-131 in the 1970s as contrasted with treatment groups in the 1950s and 1960s. The pathophysiology of this increased incidence is not known with certainty; however, infrequent use of thionamide medication, together with recent increases in dietary iodine, may render the gland more radiosensitive.
